IRIS
RINALDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.878
NA - Nord America 2.575
AS - Asia 671
AF - Africa 17
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 6.162
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.557
IE - Irlanda 1.162
IT - Italia 684
GB - Regno Unito 339
SG - Singapore 268
CN - Cina 215
DE - Germania 189
UA - Ucraina 160
GR - Grecia 82
FR - Francia 66
KR - Corea 62
FI - Finlandia 48
TR - Turchia 46
SE - Svezia 37
IN - India 24
RO - Romania 24
BE - Belgio 17
NL - Olanda 16
CZ - Repubblica Ceca 14
IR - Iran 14
CA - Canada 13
EG - Egitto 12
RU - Federazione Russa 11
ID - Indonesia 10
PK - Pakistan 8
ES - Italia 6
TW - Taiwan 6
CO - Colombia 5
PE - Perù 5
BR - Brasile 4
CH - Svizzera 4
HK - Hong Kong 4
JP - Giappone 4
EU - Europa 3
LT - Lituania 3
MK - Macedonia 3
MX - Messico 3
AT - Austria 2
CL - Cile 2
HU - Ungheria 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
UG - Uganda 2
VN - Vietnam 2
AN - Antille olandesi 1
AR - Argentina 1
AU - Australia 1
BW - Botswana 1
DK - Danimarca 1
GE - Georgia 1
HR - Croazia 1
LI - Liechtenstein 1
MA - Marocco 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 6.162
Salva come PNG Salva come JPEG
Città #
Dublin 1.148
Chandler 424
Jacksonville 291
Santa Clara 194
Princeton 160
Singapore 160
Roxbury 155
New York 150
Naples 112
Bremen 104
Cambridge 89
Caserta 85
Medford 74
Seoul 61
Ann Arbor 58
Beijing 50
Des Moines 50
Wilmington 50
Boardman 32
Ashburn 29
Napoli 29
Redwood City 26
Nanjing 25
Woodbridge 25
Munich 22
Milan 20
Washington 20
Aversa 18
Mountain View 18
Brussels 17
Atlanta 15
Jinan 15
Helsinki 14
Shenyang 14
Houston 12
London 12
Giugliano In Campania 11
Norwalk 11
Amsterdam 10
Istanbul 10
Monserrato 10
San Mateo 10
Timisoara 9
Lappeenranta 8
Marano Di Napoli 8
Taizhou 8
Brno 7
Chicago 7
Florence 7
Haikou 7
Liveri 7
Stuttgart 7
Zanjan 7
Changsha 6
Hebei 6
Lanzhou 6
Los Angeles 6
Paris 6
Perugia 6
Sacramento 6
Taipei 6
Tianjin 6
Zhengzhou 6
Duncan 5
Fairfield 5
Nanchang 5
Philadelphia 5
Samsun 5
Auburn Hills 4
Casamarciano 4
Chennai 4
Damietta 4
Groningen 4
Hangzhou 4
Hong Kong 4
Kunming 4
Lima 4
Mumbai 4
Ningbo 4
Nonantola 4
Orange 4
Pomezia 4
Rho 4
Seattle 4
Zurich 4
Andover 3
Bogotá 3
Bologna 3
Boydton 3
Buffalo 3
Carinaro 3
Changchun 3
Dearborn 3
Eboli 3
Elora 3
Hanover 3
Hefei 3
Hyderabad 3
Mohali 3
Moscow 3
Totale 4.120
Salva come PNG Salva come JPEG
Nome #
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 102
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 92
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 92
Bartter syndrome 86
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 80
Renal phenotype in bardet-biedl syndrome: A combined defect of urinary concentration and dilution is associated with defective urinary aqp2 and umod excretion 79
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 77
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 71
Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: Identification of eleven novel pathogenic sequence variants 68
Pulsed laser ablation of magnetic nanoparticles as a novel antibacterial strategy against gram positive bacteria 68
Chronic HCV infection and neurological and psychiatric disorders: an overview. 66
Sonoporation by microbubbles as gene therapy approach against liver cancer 64
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. 63
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 63
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 60
A genic and epigenetic combination therapy for liver cancer 60
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 58
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 56
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 56
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 56
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 53
Spirometry in elderly laryngectomized patients: A feasibility study 53
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 52
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 51
Relevance of lung ultrasound in the diagnostic algorithm of respiratory diseases in a real-life setting: A multicentre prospective study 51
HCV-related steatosis and risk of atherosclerosis 51
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 51
Chronic HCV infection is a risk factor of ischemic stroke 51
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 51
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 51
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 50
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 49
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 49
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 49
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 49
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 48
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 48
Chronic Hepatitis C Virus Infection and Depression. 47
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals 47
Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment. Predictive Factors and Role of Epigenetics 47
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. 46
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 46
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosi 46
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 46
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 46
Seasonal variations of hyponatremia in the emergency department: Age-related changes 45
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 45
HCC and molecular targeting therapies: Back to the future 45
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 45
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 43
Renal handling of uric acid 43
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 43
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 43
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 43
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients 42
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 42
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 42
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 41
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 41
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 41
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 41
Prediction of SARS-CoV-2-Related Lung Inflammation Spreading by V:ERITAS (Vanvitelli Early Recognition of Inflamed Thoracic Areas Spreading) 41
Patho-physiology of renal dysfunction in Bardet-Biedl Syndrome 40
Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes 40
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 40
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment 40
Cardiovascular benefits from gliflozins: Effects on endothelial function 40
[Next Generation Sequencing and ADPKD] 39
Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact 39
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 39
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 39
Steatosis is a determinant of fibrosis progression in chronic hepatitis C and is correlated both with body composition and viral factors 37
High HDL Cholesterol: a risk factor for Diabetic Retinopathy? Findings from NO BLIND study 37
Diagnostic performance of LI-RADS in adult patients with rare hepatic tumors 37
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 37
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 36
Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis 36
Atypical presentation of a rare parasitic infection with fasciola hepatica: A multidisciplinary case report 36
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 36
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 35
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 34
Nonalcoholic fatty liver disease: Evolving paradigms 34
Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients 34
Non-alcoholic fatty liver disease beyond the liver is an emerging multifaceted systemic disease 34
Hepatocellular carcinoma in patients with cryptogenic and metabolic cirrhosis: Incidence, characteristics, risk factors and survival 34
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 34
The importance of the thick ascending limb of Henle's loop in renal physiology and pathophysiology 33
Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress 33
Association between the spread of COVID-19 and weather-climatic parameters 33
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review 33
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 33
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage 32
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis. 32
TISSUE RESONANCE INTERACTION METHOD: A CHALLENGE FOR THE EARLY AND NON-INVASIVE DIAGNOSIS OF SOLID CANCERS 32
Oncolytic viruses in combination therapeutic approaches with epigenetic modulators: Past, present, and future perspectives 32
Editorial - Direct-acting antivirals therapy in HCV patients with HCC: lights and shadow 32
Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis. 31
Angiogenesis inhibitors for the treatment of hepatocellular carcinoma 31
Antioxidant diet and genotyping as tools for the prevention of liver disease 31
SARS-CoV-2 vaccine development: Where are we? 31
Totale 4.707
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020334 0 0 0 0 69 18 97 29 24 26 49 22
2020/2021646 29 28 40 32 111 35 149 43 16 39 94 30
2021/20221.019 25 4 16 29 309 20 15 23 72 75 96 335
2022/20232.051 187 64 56 92 254 125 6 107 1.051 21 38 50
2023/20241.167 85 28 57 68 322 177 37 38 22 43 106 184
2024/2025563 30 72 27 74 360 0 0 0 0 0 0 0
Totale 6.611